Similar Articles
31 N-glycan biosignatures as a potential diagnostic biomarker for early-stage pancreatic cancer
32 Verteporfin fluorescence in antineoplastic-treated pancreatic cancer cells found concentrated in mitochondria
33 Extended survival with metastatic pancreatic cancer under fruquintinib treatment after failed chemotherapy: Two case reports
34 Circulating tumor cells as prognostic marker in pancreatic cancer
35 Erlotinib combination with a mitochondria-targeted ubiquinone effectively suppresses pancreatic cancer cell survival
36 Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept study from the PANTHEIA-SEOM trial
37 Circulating tumor cells as potential prognostic biomarkers for early-stage pancreatic cancer: A systematic review and meta-analysis
38 Glutamine addiction and therapeutic strategies in pancreatic cancer
39 Paraneoplastic myopathy-related rhabdomyolysis and pancreatic cancer: A case report and review of the literature
40 Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA